A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

NCT01898598 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

DRUG: Placebo
DRUG: Vismodegib

Sponsor

Hoffmann-La Roche